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MDM2 facilitates adipocyte differentiation through
CRTC-mediated activation of STAT3
P Hallenborg1, M Siersbæk1, I Barrio-Hernandez1, R Nielsen1, K Kristiansen2, S Mandrup1, L Grøntved1 and B Blagoev*,1
The ubiquitin ligase MDM2 is best known for balancing the activity of the tumor suppressor p53. We have previously shown that
MDM2 is vital for adipocyte conversion through controlling Cebpd expression in a p53-independent manner. Here, we show that the
proadipogenic effect of MDM2 relies on activation of the STAT family of transcription factors. Their activation was required for
the cAMP-mediated induction of target genes. Interestingly, rather than influencing all cAMP-stimulated genes, inhibition of the
kinases directly responsible for STAT activation, namely JAKs, or ablation of MDM2, each resulted in abolished induction of a
subset of cAMP-stimulated genes, with Cebpd being among the most affected. Moreover, STATs were able to interact with the
transcriptional cofactors CRTC2 and CRTC3, hitherto only reported to associate with the cAMP-responsive transcription factor
CREB. Last but not least, the binding of CRTC2 to a transcriptional enhancer that interacts with the Cebpd promoter was
dramatically decreased upon JAK inhibition. Our data reveal the existence of an unusual functional interplay between STATs and
CREB at the onset of adipogenesis through shared CRTC cofactors.
Cell Death and Disease (2016) 7, e2289; doi:10.1038/cddis.2016.188; published online 30 June 2016
Terminal differentiation is the final step in the long sequence of
turning a stem cell into a unipotent, specialized cell. With the
ongoing obesity epidemic, the adipocyte fate has been
attracting more and more attention. These fat-laden cells
originate from the mesenchymal stem cells (MSCs), and the
understanding of the transcription factor network orchestrating
adipogenesis has increased dramatically in the recent years.
Within its very core lies the peroxisome-proliferator activated
receptor γ (PPARγ).1 Yet, induction of PPARγ expression does
not occur at the onset in the process of turning an MSC into an
adipocyte. Its expression is controlled by other proadipogenic
transcription factors, of which CCAAT/Enhancer binding
protein β (C/EBPβ) and C/EBPδ are the best described. Their
expression, which is boosted shortly after induction of
differentiation, is mainly controlled by members of the signal
transducer and activator of transcription (STATs) family as well
as cAMP-element binding protein (CREB).2
STATs are sequestered in the cytoplasm until activated by
tyrosine phosphorylations which leads to translocation to the
nucleus and induction of target genes. Of the seven known
STATs, only STAT3 and STAT5 are reported to positively affect
adipogenesis.3–7 Similarly, CREB has also been shown to
enhance adipocyte differentiation.8–10 Interestingly, although a
dominant-negative CREB prevents induction of Cebpb during
differentiation, a constitutive active CREB restores adipogen-
esis in cells with knockdown of C/EBPβ, suggesting that
CREB facilitates adipose conversion through others means
than C/EBPβ.8,10
CREB is constitutively nuclear and upon phosphorylation
recruits general cofactors such as p300/CBP (CREB-binding
protein) to activate transcription.11 However, CREB recruits
more specialized coactivators as well. The CREB-regulated
transcriptional coactivators (CRTCs), of which three are
known, are only reported to bind and activate CREB.12
Interestingly, ectopic expression of a dominant-negative
CRTC is able to decrease adipogenesis.13
Here we demonstrate that CREB does not have exclusive
rights to CRTCs and that it shares these cofactors with the
STATs for cooperative regulation of adipocyte differentiation.
We show that ablation of the ubiquitin ligase MDM2 leads to
dysfunctional STATactivation. Inhibition of the JAKs, which are
the main kinases responsible for STAT activation, resulted in
decreased binding of CRTC2 to an enhancer region, which
interacts with Cebpd transcriptional start site (TSS), and
dramatically reduced adipocyte conversion.
Results
Knockdown of MDM2 prevents Cebpd induction and
adipocyte differentiation in a p53-independent manner.
In our previous work we have seen a necessity for MDM2 in
the induction of Cebpd, but not Cebpb, at the onset of adipo-
cyte differentiation in mouse embryonic fibroblasts (MEFs).
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This resulted in a decreased adipose conversion of MEFs
lacking MDM2.13 We sought to corroborate these findings in a
classic preadipocyte cell line. In agreement with the findings
in the MEFs, the cAMP-mediated induction of Cebpd, but not
Cebpb, was impaired in 3T3-L1 preadipocytes with knock
down of MDM2 (Figures 1a and b). Also, 3T3-L1 cells with
decreased levels of MDM2 were less efficient in undergoing
adipogenesis (Figures 1c and d).
Despite the importance of MDM2 in regulating p53
abundance, the level of the tumor suppressor was not
upregulated in 3T3-L1 cells upon MDM2 knockdown
(Figure 1a), indicating that the involvement of MDM2 in
regulation of Cebpd induction was p53-independent, as
reported earlier.13 This was further substantiated by the
inability of Nutlin-3, which increases p53 levels by preventing
its binding to MDM2,14 to modulate the cAMP-mediated
increase in Cebpd expression (Figure 1e). The stimulation of
Cdkn1a (Cyclin-dependent kinase inhibitor 1a, encoding p21)
confirmed that 3T3-L1 cells do possess functional p53
(Figure 1e).
Collectively, these data show the previously reported role of
MDM2 in MEF adipogenesis can be recapitulated in the
3T3-L1 preadipocyte model.
MDM2 deficiency leads to perturbed STAT activation. To
obtain possible cues for the p53-independent effect of MDM2
on Cebpd expression and adipocyte differentiation we used
SILAC-based quantitative mass spectrometry (qMS)15,16 to
get a snapshot of the global proteome of MEFs with and
without Mdm2. p53−/− and p53−/−;mdm2−/− MEFs were
grown in light and heavy stable isotope-labeled amino acids,
lysates mixed in equal amounts, digested with trypsin and
subjected to qMS (Supplementary Figure S1 and
Supplementary Table S3). Interestingly, several STAT targets
were higher expressed in cells harboring Mdm2 (Figure 2a).
Although the protein levels of the two proadipogenic STATs,
STAT3 and STAT5, did not differ between MEFs of the two
genotypes, the best described activating phosphorylation of
STAT3, tyrosine 705, was blunted in cells lacking Mdm2. In
contrast, the homologous phosphorylation of STAT5 on
tyrosine 694 was similar (Figure 2b). These tyrosine residues
are mainly phosphorylated by the family of Janus Kinases
(JAKs), which is composed of four members: JAK1, JAK2,
JAK3 and TYK2. In contrast to the others, JAK3 expression is
largely confined to the cells of the hematopoietic system.
Curiously, levels of JAK1, JAK2 or TYK2 as well as their
activating phosphorylations were identical in cells with and
without Mdm2. Still, the tyrosine phosphorylations of STAT3
and STAT5 were sensitive to the pan-JAK inhibitor P6
(Figure 2b), suggesting that MDM2 is important in conveying
signals from JAKs to at least STAT3.
To explore if inhibition of the JAKs in 3T3-L1 preadipocytes
could mimic the result of MDM2 deficiency, we treated these
cells with P6. Similar to the situation in the MEFs, the inhibitor
prevented tyrosine phosphorylation of STAT3 and STAT5 both
in the presence or absence of forskolin in 3T3-L1 cells
(Figure 2c). Along the same line, whereas P6 did not affect the
cAMP-mediated induction of Cebpb, it did impair the ability
of the second messenger to augment Cebpd expression
(Figure 2d). Finally, P6 also prevented adipose conversion of
the 3T3-L1 cells (Figures 2e and f).
JAKs have previously been suggested to be necessary for
induction of Cebpb in 3T3-L1 preadipocytes.17 However, the
JAK inhibitor used in that study, AG490, is also a potent
inhibitor of the epidermal growth factor receptor (EGFR).18 We
therefore tested if inhibition of members of the EGFR family
would affect expression of Cebpb and Cebpd. Indeed,
induction of both transcripts by cAMP was decreased in
Figure 1 MDM2 knockdown but not Nutlin-3 treatment lowered cAMP-mediated
induction of Cebpd. (a–d) MDM2 or control (GFP) was knocked down in confluent
3T3-L1 preadipocytes using siRNA transfection. (a) Protein levels of MDM2, p53 and
α-tubulin 48 h post transfection. (b) Transfected cells were stimulated with forskolin or
vehicle for 1 h. mRNA levels of Cebpb and Cebpd were measured by real-time qPCR.
(c and d) Transfected cells were induced to undergo adipocyte differentiation. Degree
of adipogenesis was scored by Oil-Red-O staining of triglycerides (c) or mRNA levels
of adipocyte marker genes by real-time qPCR (d). (e) 3T3-L1 preadipocytes were
treated with either Nutlin-3 or vehicle before stimulation with forskolin. mRNA levels of
Cebpb, Cebpd and Cdkn1a were measured by real-time qPCR. *Significance tested
using Student’s t-test, Po0.05
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3T3-L1 cells treated with the EGFR family inhibitor Canertinib
(Supplementary Figure S2A). In agreement with the effect of
P6 on Cebpd only, two other JAK specific inhibitors, Baritinib
and Ruxolitinib, prevented induction of Cebpd but not Cebpb
(Supplementary Figures S2B and C).
Recently, STAT3 was reported to convey signals from TYK2
and thereby regulate brown adipocyte differentiation.19 As P6
inhibits the kinase activity of all JAK family members, we
included a TYK2-specific inhibitor during forskolin-stimulated
and differentiating 3T3-L1 preadipocytes to examine whether
TYK2 is responsible for STATactivation in these cells. However,
inhibition of TYK2 did neither prevent cAMP-mediated induction
of Cebpd, STAT3 and STAT5 phosphorylation nor adipocyte
differentiation (Supplementary Figure S3).
Collectively, these data argue that MDM2 regulates
adipogenesis through the JAK–STAT3–Cebpd pathway. To
our knowledge, MDM2 has hitherto not been associated
with JAK–STAT signaling. However, MDM2 is known to
interact with the insulin-like growth factor 1 receptor
(IGF-1R), which partially signals through JAKs.20 Even though
chemical inhibition of the IGF-1R prevented adipogenesis of
3T3-L1 cells, it did not prevent cAMP-mediated induction
of Cebpd, arguing against an involvement of IGF-1R
in the observed MDM2-dependent STAT3 activation
(Supplementary Figure S4).
JAK activity regulates only a subset of cAMP target
genes. cAMP is known to regulate the expression of a
myriad of genes.21,22 To define the cAMP-activated gene
program dependent on the JAKs we performed RNA-seq
analyses in both 3T3-L1 cells and the MEFs.
First, 3T3-L1 preadipocytes pre-treated with P6 or vehicle
were stimulated for 1 h with forskolin or vehicle. As depicted in
Figure 3a, only a specific subset of the cAMP-stimulated
genes was affected by the inclusion of the JAK inhibitor
(the entire list is appended as Supplementary Table S4).
Notably,Cebpdwas themost severely decreased target for P6
in 3T3-L1 preadipocytes, whereas the mRNAs of a few other
transcription factors such as Fos, Fosb and Junb were also
lowered by the JAK inhibitor.
Second, p53−/− and p53−/−;mdm2−/−MEFswere stimulated
for 1 h with forskolin or vehicle. The relative differences in
cAMP-induction are shown in Figure 3b and Supplementary
Table S4. Although more genes were influenced by the lack of
Mdm2 in MEFs compared with P6 treatment in 3T3-L1 cells,
Cebpd was again among the most severely affected. In
agreement with the aforementioned qPCR analyses, Cebpb
Figure 2 MDM2 is needed for STATactivation. (a) Visualization of MS-based SILAC ratios for known STAT targets. Yellow-colored nodes are upregulated in p53−/− MEFs.
(b) p53−/− and p53−/−;mdm2−/− MEFs were treated with the JAK inhibitor, P6. Protein and phosphorylation levels of JAKs and the adipogenic STATs were measured using
western blotting. (c and d) 3T3-L1 preadipocytes were treated with P6 and/or forskolin. (c) Western blot analyses of protein and phosphorylation levels of the proadipogenic
STATs. (d) mRNA levels of Cebpb and Cebpd as assessed by real-time qPCR. (e and f) P6 or vehicle was included during adipogenesis of 3T3-L1 cells. Levels of differentiation
were scored by Oil-Red-O staining of triglycerides (e) or mRNA levels of adipocyte marker genes by real-time qPCR (f). *Significance tested using Student’s t-test, Po0.05
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levels were neither influenced by the P6 in 3T3-L1 cells nor by
MDM2-ablation in the MEFs (Figures 3a and b).
The global expression analyses in both P6-treated
3T3-L1 cells and Mdm2-deficient MEFs strongly suggested
that C/EBPδ was a key factor in the impaired adipogenesis in
the two settings. This notion was further supported by our
previous observation that ectopic expression of C/EBPδ was
able to restore adipocyte differentiation in Mdm2-deficient
MEFs.13 Consistent with this, forced expression of C/EBPδ
was able to at least partially circumvent the P6-imposed block
of adipogenesis in 3T3-L1 cells (Figures 3c–e).
Collectively, these data argue that JAK/STAT–MDM2 axis is
involved in the regulation of a subgroup of cAMP-regulated
genes at the onset of adipocyte differentiation. The adipogenic
transcription factor C/EBPδ is one of the genes that is most
dependent on this axis. Yet, it is possible that JUN and FOS
family members partake in the development as ectopic
expression of A-ZIP, which is dominant negative towards
C/EBP and JUN families, suffer from a much more severe fat
loss compared mice lacking C/EBPβ and C/EBPδ.23,24
CRTC2 binds to an enhancer near Cebpd in a
JAK-dependent manner. Our previous work suggested an
impaired recruitment of the CREB cofactor CRTC2 to the
Cebpd promoter in p53−/−;mdm2−/− MEFs upon elevated
cAMP levels.13 The approach was however biased as we only
looked at CRTC2 recruitment to putative CREB-binding sites
in the immediate vicinity of the Cebpd TSS. To assess
possible involvement of CRTC2 in the JAK/STAT–MDM2 axis,
we analyzed global CRTC2 chromatin binding in forskolin-
stimulated 3T3-L1 cells upon P6 or vehicle treatment.
Although CRTC2 was found recruited to more than 17 000
sites in forskolin-stimulated cells, only a minor fraction was
significantly affected by JAK inhibition (Figure 4a, 746 sites
reduced more than 1.5-fold in response to P6). Motif analyses
revealed that STAT-binding sites were more enriched in the
pool of sites with reduced CRTC2 binding in the presence of
P6 compared with unchanged CRTC2-binding sites. CREB
and the closely related AP-1-binding sites were most
significantly enriched among both the affected and unaffected
peaks (Supplementary Figure S5) and enrichment was
similar within affected and unaffected CTRC2-binding sites
(Figure 4b).
One of the most JAK-dependent CTRC2-binding sites is
located 61 kb downstream of the Cebpd gene (Figures 4a
and c). Interestingly, this region was previously shown to be
bound by members of the STAT family (Figure 4c).7,25 The
large distance between the CRTC2-binding site and the
Figure 3 JAK inhibition mainly affects cAMP-mediated induction of Cebpd. (a) Volcano plots of the effect of P6 on forskolin-induced genes in 3T3-L1 cells. (b) Volcano plots of
the effect of Mdm2 deficiency on forskolin-induced genes in MEFs. (c–e) 3T3-L1 preadipocytes were retrovirally transduced with C/EBPδ or empty vector. (c) mRNA levels of
Cebpd at day 0 as measured by real-time qPCR. (d and e) P6 or vehicle were included during adipogenesis of transduced 3T3-L1 cells. Levels of differentiation were scored by
Oil-Red-O staining of triglycerides (d) or mRNA levels of adipocyte marker genes by real-time qPCR (e). *Significance tested using Student’s t-test, Po0.05
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Cebpd TSS argued that the chromatin had to adopt a
configuration that would bring the two regions into spatial
vicinity of each other if CRTC2 had to affect transcription of
Cebpd. Such three-dimensional structural arrangements
can be investigated through the chromosome conformation
capture (3C) assay.26 The schematic of the Cebpd locus with
the putative CRTC2-bound enhancer, HindIII digestion sites
with their corresponding primers for the 3C analyses, as well
as possible structures of the chromatin is depicted in Figure 4c
and Supplementary Figure S5B. Analyses of the digestion
efficiency of HindIII near TSS, control and enhancer regions
showed that at each site approximately 80% of the chromatin
was cut (Supplementary Figure S5C). Interestingly, only when
using primers specific for the enhancer-TTS, and not the
control-TSS, conformation resulted in amplicon formation,
showing that the enhancer region was indeed in close
proximity to the Cebpd TSS in forskolin-treated 3T3-L1 cells
both in the presence and absence of P6 (Figure 4d).
These data suggest that the CRTC2 binding to a STAT site
within the +61 kb enhancer near the Cebpd promoter is
dependent on JAK activity and that this CRTC2-binding site
loops and interacts specifically with Cebpd TSS.
CRTC2 and CRTC3 exerts redundant function in the
induction of Cebpd. The data shown above argued that
CRTC2 is essential for induction of Cebpd downstream of
cAMP. We therefore examined the ability of 3T3-L1 cells with
lowered level of CRTC2 to augment Cebpd expression upon
cAMP stimulation. However, knockdown of CRTC2 did not
prevent the induction of Cebpd (Figures 5a and b).
This was seemingly in contrast to the previous observation
that ectopic expression of a dominant-negative CRTC
(DN-CRTC) was shown to inhibit the cAMP-mediated induc-
tion of Cebpd in MEFs.13 An effect that was repeatable in
3T3-L1 cells (Figure 5c), hinting that another CRTC may be
redundant to CTRC2 functions. As expression of CRTC1 is
restricted to cells of the central nervous system,27,28 we
focused on CRTC3. Interestingly, knockdown of CRTC3 itself
did not affect the cAMP-mediated increase inCebpd induction.
However, only concomitant knockdown of both CRTC2 and
Figure 4 Binding of CRTC2 to Cebpd-associated enhancer is hindered by JAK inhibition. (a–c) ChIP-Seq of CRTC2 from 3T3-L1 cells treated with either vehicle or P6 was
stimulated with forskolin. A total of 17 552 CTRC2 peaks were identified in forskolin-treated cells. (a) MA plot showing CRTC binding affected by P6. Differentially bound CRTC2
was identified using EdgeR and the false discovery rate (FDR) of individual CTRC2-binding sites is indicated in the plot. (b) Boxplots of CREB, AP-1 and STAT motif strength
within CRTC2-binding sites either unaffected or reduced by P6. Unchanged binding is defined as differential binding with FDR40.8 and reduced binding is defined as differential
binding with FDRo0.2 and log2 fold changeo0. (c) ChIP-seq profiles of Cebpd locus. STAT1, STAT3 and DHS data are from Siersbæk et al. (REF). Primer sets used for 3C
analysis are indicated together with HindIII sites. Primers 1 and 2 anneal at the HindIII sites surrounding the Cebpd TSS. Primers 3 and 4 anneal at a DNase inaccessible control
region 40 kb downstream of the TSS and primers 5 and 6 anneal at the 61 kb enhancer occupied by CRTC2 and STATs. (d) 3C analysis of interaction between 61 kb enhancer
and control region with Cebpd TSS. Ligation efficiency was normalized to ligation efficiency of HindIII-digested BAC RP23-77N6 containing the Cebpd locus
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CRTC3 significantly decreased the cAMP-mediated induction
of Cebpd (Figures 5a and b).
These data show that both CRTC2 and CRTC3 can
substitute for each other in the induction of Cebpd.
CRTCs bind STATs and MDM2. In order to understand how
the interplay between JAK/STAT, CRTCs and MDM2 could
regulate induction of Cebpd, we analyzed which of the
individual components were able to interact. We found that
CRTC2 and CRTC3 were able to bind the two adipogenic
STATs, although both CRTCs bound stronger to STAT3
compared with STAT5 (Figure 6a).
MDM2 has previously been shown to interact directly with
andmodulate the activity of several transcription factors.29,30 It
is, however, unlikely that the decreased STATactivity in p53−/−;
mdm2−/− MEFs is due to direct binding of MDM2 to STATs as
they failed to interact based on co-immunoprecipitation
experiments (Figure 6b). In contrast, MDM2 was able to
readily associate with the upstream kinase, JAK1 (Figure 6c).
This suggests that MDM2 regulates STATactivation indepen-
dent of direct binding to the transcription factors. Besides
binding to JAK1, MDM2 was also able to interact with both
CRTC2 and CRTC3, hinting to a deeper involvement of MDM2
in Cebpd induction than just activation of STAT3 (Figures 6d
and e).
Collectively, these data show that several of the constituents
of the MDM2–JAK/STAT–CRTC network are able to interact.
Chromatin binding of CRTCs is modulated by P6 and
MDM2. Both STATs and CRTCs are cytoplasmic proteins
that translocate to the nucleus upon stimulation. We therefore
examined the levels of the STAT3 and CRTCs in MEFs
separated into cytosolic and nuclear fractions. STAT3 was
only found in the nuclei of p53−/− MEFs (Figure 7a). This
correlates with the increased phosphorylation status of
STAT3. Interestingly, the two CRTCs had different distribu-
tions. Whereas CRTC2 entered the nucleus upon forskolin
stimulation in MEFs of both genotypes, CRTC3 translocation
was drastically reduced in MEFs lacking Mdm2 (Figure 7a).
When fractionating cells under more stringent conditions, it
is possible to solubilize nuclear proteins together with the
cytosol and separate it from the chromatin and large
cytoskeletal structures. Interestingly, although CRTC2 was
able to enter the nuclei in both p53−/− and p53−/−;mdm2−/−
MEFs, it was bound less tightly to chromatin in cells lacking
MDM2. Consistent with the dysfunctional translocation of
CRTC3 in p53−/−;mdm2−/− MEFs, it was not found in the
chromatin fraction of these cells (Figure 7b).
To elucidate if JAK activity was needed for the translocation
of the CRTCs, we fractionated 3T3-L1 cells treated with P6
and/or forskolin. Although the translocation of CRTC2 was
unaffected by the inhibitor, its binding to chromatin was
decreased (Figures 7c and d). On the other hand, binding of
CRTC3 to DNA was unaffected by the inhibitor (Figure 7d)
again arguing for different modes of regulation of the two
related coactivators.
Collectively, these data show that MDM2 regulates the
function of CRTC2 and CRTC3 by controlling their chromatin
binding and nuclear translocation, respectively.
Discussion
We show here that inhibition of JAKs, the kinases responsible
for activation of the STAT transcription factors, attenuated
adipogenesis in 3T3-L1 preadipocytes by preventing the
cAMP-mediated induction of Cebpd but not Cebpb. STATs
seemingly cooperated with the two cAMP-activated cofactors,
CRTC2 and CRTC3, and JAK inhibition also modulated the
binding of the CRTCs to chromatin. This interplay was highly
dependent on MDM2 as lack of MDM2 caused decreased
phosphorylation of STAT3, lowered binding of CRTC2 to
chromatin and improper nuclear translocation of CRTC3 upon
cAMP stimulation. The suggested interplay is depicted in
Figure 8.
It is notable that the STATs were able to bind the CRTC
cofactors. Hitherto, these cofactors have to our knowledge
only been ascribed to activation of CREB and other members
of the basic leucine zipper (bZIP) family of transcription
factors.12,31–33 However, the CRTCs are not the only shared
cofactors between bZIPs and STATs. Both families associated
with the acetyl transferases p300 and CBP.34–36 As CRTCs in
part augmented CREB activity by facilitating the recruitment of
Figure 5 CRTC2 and CRTC3 share function and STAT binding. (a and b) CRTC2 and/or CRTC3 were knocked down in 3T3-L1 cells. (a) Confirmation of knockdowns by
western blotting. (b) mRNA levels of Cebpb and Cebpd in forskolin-stimulated 3T3-L1 cells. *Significance tested by one-way ANOVA followed by Tukey's post hoc tests, Po0.05.
(c) 3T3-L1 cells were retrovirally transduced with DN-CRTC or empty vector. Forskolin-mediated increase in Cebpb and Cebpd was analyzed by real-time qPCR. *Significance
tested using Student’s t-test, Po0.05
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p300/CBP to CREB-binding sites,37 it is likely that the CRTCs
can strengthen the association between STATs and
p300/CBP.
Recent insights have indeed shown that transcription
factors collaborated in the orchestration of adipogenesis.2,25
Although our results here suggested that the induction of
Cebpd relied on CTRC–STAT interplay, we strongly believe
that the classic partner of the CRTCs, CREB, was also a part
of this complex. This hypothesis is supported by the finding
that P6 reduced the binding of CRTC2 to CREB-binding motifs
(Figure 4b).
CRTC2 and CRTC3 shared overlapping functions in the
induction of Cebpd by cAMP at the onset of adipogenesis.
Interestingly, mice with knockout of either of the two had
phenotypical changes in their adipose stores. Adipose mass
tended to be lower in mice with ablated CRTC233 and
knockdown of CRTC2 decreased the lipid content of differ-
entiating 3T3-L1 cells.38 On the other hand, mice lacking
CRTC3 displayed a severely decreased adipose mass
although this was due to increased energy expenditure in
the brown adipose tissue.28 Based on the findings presented
here, it is, however, possible that a severe defect in
adipogenesis in vivo would only be evident in mice lacking
both CRTC2 and CRTC3 due to redundancy between the two
cofactors.
Our data here indicate that MDM2 was vital for conveying
the signals from JAKs to at least STAT3, possibly through
direct interaction with the JAKs. Besides its kinase domain, the
JAKs are composed of an SH2, a pseudokinase and an FERM
domain, which all contribute to the regulation of JAK activity.39
The FERM domain is of special interest as MDM2 has been
shown to bind the FERM regions of the focal adhesion kinase
1 and 2 (FAK and FAK2/PYK2).40,41 Interestingly, the FERM
domains of JAKs shared the highest similarities with those of
the FAKs compared with FERM domains of other proteins.42
For both FAK1 and PYK2, the FERM domain was needed for
the positive effect of the kinases on MDM2-facilitated p53
ubiquitination and degradation. It is, however, highly likely that
MDM2 returns the favor by regulating activation of FAK/PYK2
as binding partners of the FERM domains controlled the
activity of the kinases.42
The same is possible for the JAKs. The FERM region has
in several incidences been shown to be necessary for
receptor binding and JAK activation through conformation
changes.43–45 It is therefore likely that by binding to the FERM
domain, MDM2 can alter the folding of the JAKs and thereby
Figure 6 CRTCs can bind STAT3, STAT5 and MDM2. (a) 293T cells were transfected with FLAG-tagged CRTCs and/or STATs. FLAG-immunoprecipitates (IPs) were
analyzed for STAT3 and STAT5 by western blotting. (b) 293T cells were transfected with MYC-tagged MDM2 and/or STATs. MYC-IPs were analyzed for STAT3 and STAT5 by
western blotting. (c) 293T cells were transfected with MYC-tagged MDM2 and/or JAK1. MYC-IPs were analyzed for JAK1 by western blotting. (d) 293T cells were transfected with
FLAG-tagged CRTC2 and/or MDM2. FLAG-IPs were analyzed for MDM2 by western blotting. (e) 293T cells were transfected with FLAG-tagged CRTC3 and/or MDM2. FLAG-IPs
were analyzed for MDM2 by western blotting
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facilitate their recruitment to receptors and subsequent
activation.
Interestingly, whereas CRTC2 was able to shuttle into the
nucleus upon cAMP stimulation, CRTC3 failed to do so in
the absence of MDM2. However, despite being able to enter
the nucleus the binding of CRTC2 to the chromatin was
significantly reduced in cells lacking MDM2. These data argue
that MDM2 has different modes of regulating CRTC2
and CRTC3. This notion was further strengthened by the
observation that overexpression of MDM2 leads to a dramatic
downregulation of CRTC2 but not CRTC3, suggesting that
MDM2 may ubiquitinate CRTC2 (Figures 6d and e). It is
possible that a direct association between MDM2 and CRTC2
as well as ubiquitination of the latter facilitates DNA binding.
Ubiquitination comes in many forms and can even
promote transcription.46,47 The destructive effect of ectopic
expression of MDM2 on CRTC2 could be an artifact from the
ectopic expression as MDM2 at low levels leads to mono-
ubiquitination of p53 and only at high levels MDM2 poly-
ubiquitinates p53.48
In addition, decreased STAT3 phosphorylation in cells
lacking MDM2 probably also contributed to the lowered
binding of CRTC2 to DNA, as the JAK inhibitor P6 lowered
CRTC2 recruitment to the Cebpd enhancer.
Materials and Methods
Plasmids. pBABE-puro was a generous gift from Dr Ormond MacDougald.
pBABE-puro C/EBPδ was described previously.13 pcDNA3 was kindly provided by
Dr Jean-Christophe Marine. pCMV FLAG-MYC-CRTC2 was donated by Dr. Jeffrey
Meier. pcDNA FLAG CRTC3 was a gift from Dr. Marc Montminy (Addgene,
Cambridge, MA, USA; plasmid # 22976).12 pRK5 JAK1 was used previously.49
pcDNA3 STAT3 was a generous gift from Dr Jim Darnell (Addgene; plasmid
#8706).50 STAT5 was moved from pMX (kindly provided by Dr Andrew Brooks) to
pcDNA3.1.
Cell culture and differentiation. p53−/− and p53−/−;mdm2−/− MEFs were
generous gifts from Dr. Guillermina Lozano. All cells were grown in Dulbecco’s
modified Eagle's medium (DMEM) with 4.5 g/l glucose (Gibco, Thermo Fisher
Scientific, Waltham, MA, USA), 100 U/ml Penicillin–Streptomycin (Lonza, Basel,
Switzerland) and 2 mM L-glutamin (Lonza). For growth of 3T3-L1, the medium was
supplement with 10% calf serum. For growth of MEFs, H4IIE, HEK293T and
Phoenix cells as well as differentiation of 3T3-L1 preadipocytes, the medium was
supplemented with 10% fetal bovine serum (FBS) (Gibco).
For mass-spectrometry (MS)-based proteomic analysis, MEFs were grown in
DMEM deficient in arginine and lysine supplemented with dialyzed FBS (Gibco),
100 U/ml penicillin–streptomycin and 2 mM L-glutamin. Cells were SILAC labeled15
with either L-arginine (Arg0) and L-lysine (Lys0) or L-arginine-13C6 (Arg6) and L-lysine
2H4 (Lys4) (Cambridge Isotope Laboratories, Inc., Tewksbury, MA, USA).
Stimulation with 10 μM forskolin (LC Laboratories, Woburn, MA, USA) was carried
out for 15 min for subsequent protein and ChIP analyses and 1 h for RNA analyses.
Vehicle or inhibitors were added to cells 15 min prior to addition of forskolin. Inhibitors
used were 500 nM P6 (Pyridone 6) (Calbiochem, Merck, Darmstadt, Germany),
500 nM PPP (Picropodophyllin) (Calbiochem), 10 μM Bayer-18 (Symansis, Timaru,
Figure 7 MDM2 regulates localization and chromatin binding of CRTCs. (a and b) p53−/− and p53−/−;mdm2−/− MEFs were stimulated with vehicle or forskolin for 15 min.
Cells were then fractioned into cytosolic and nuclei (a) or cyto/nucleosol and chromatin (b). (c and d) 3T3-L1 cells treated with vehicle or P6 were stimulated with vehicle or
forskolin for 15 min. Cells were then fractioned into cytosolic and nuclei (c) or cyto/nucleosol and chromatin (d)
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New Zealand), 10 μM Nutlin-3 (Santa Cruz Biotechnologies, Dallas, TX, USA),
10 μM Canertinib (Selleckchem, Houston, TX, USA), 500 nM Baritinib (Sellechchem)
or 500 nM Ruxolitinib. All were dissolved in dimethyl sulfoxide (DMSO) (Sigma-
Aldrich, St. Louis, MO, USA).
Two days past confluence (denoted day 0), adipogenesis of 3T3-L1 cells was
induced by supplementing differentiation medium with 500 μM isobutylmethyl-
xanthine (Sigma-Aldrich), 1 μM dexamethasone (Sigma-Aldrich) and 1 μg/ml insulin
(Sigma-Aldrich). From day 2 to day 4, only 1 μg/ml insulin was added to the
differentiation medium. Cells were subsequently refed every second day with
adipogenic medium.
For Oil-Red-O staining, cells were rinsed in PBS, and fixed for in 3.7%
paraformaldehyde for 10 min. After aspiration of the paraformaldehyde solution, cells
were rinsed in water, incubated with Oil-Red-O solution (0.3 g Oil-Red-O (Sigma-
Aldrich) in 60 : 40 isopropanol /water solution) for 1 h and rinsed several times with
water. After the last wash, cells were left with water.
siRNA-mediated knockdown. RNAiMAX (Thermo Fisher Scientific) was
mixed with MISSION esiRNAs (Sigma-Aldrich) in Opti-MEM (Thermo Fisher
Scientific) and aliquoted in gelatin-coated plates. Confluent 3T3-L1 preadipocytes
were detached by trypsination, suspended in medium, spun down and resuspended
in medium. Hereafter, cells were seeded onto esiRNA:RNAiMAX complexes. This
was repeated the following day.
Retroviral transduction. Phoenix cells were transfected with pBABE-based
plasmids. At 2 days post transfection, media were isolated, spun down at 1200 g for
5 min to remove cellular debris, mixed 1 : 1 with standard media and added to cells.
Polybrene (Sigma-Aldrich) was added to a final concentration of 8 μg/ml. The cells
were not selected with puromycin.
RNA purification, reverse transcription and real-time qPCR. RNA
was purified using Isol-RNA lysis reagent (5 PRIME, Hilden, Germany) according to
the manufacturer’s instructions. For generation of cDNA, 1 μg of RNA was reverse
transcribed using MMLV (Thermo Fisher Scientific) according to the manufacturer’s
instructions. Quantitative PCR was performed in 10 μl reactions containing SYBR
Green JumpStart Taq ReadyMix (Sigma-Aldrich), 3 μl of diluted cDNA and 300 nM
of each primer. Reaction mixtures were preheated at 95 °C for 2 min followed by 40
cycles of melting at 95 °C for 15 s, annealing at 60 °C for 30 s, elongation at 72 °C
for 45 s on the LightCycler platform (Roche, Basel, Switzerland). Sequences of
primers (Pentabase, Odense, Denmark) sequences are listed in Supplementary
Table S1. Tfiib mRNA levels were used for normalization.
Western blotting. Cells were harvested in lysis buffer (50 mM Tris-HCl, pH 8.0,
500 mM NaCl, 1% NP-40, 1 mM EDTA, 0.25% NaDeoxycholate, 1.5% SDS,
protease inhibitors (Complete) (Roche), 5 mM NaF, 5 mM β-glycerophosphate,
1 mM Na3VO4) and sonicated 2 × 5 s at 20% amplitude (Q500) (Qsonica, Newtown,
CT, USA). For SDS-PAGE, 100 μg of protein were diluted 5 : 6 in Laemmli buffer
(0.3 M Tris, pH 6.8, 12% SDS, 40% glycerol, 0.05% bromophenol blue), heated to
95 °C for 5 min and loaded into each lane. After separation, proteins were blotted
onto nitrocellulose paper (GE Healthcare, Little Chalfont, UK) using a Hoefer
SemiPhor blotter. Membranes were blocked 1 h at room temperature in either 5%
milk or 2% BSA in PBS/T (PBS with 0.1% Tween (Sigma-Aldrich)). Incubation with
primary antibodies was carried out overnight. Membranes were rinsed with PBS/T,
incubated with horseradish-coupled secondary antibodies (GE Healthcare) and
rinsed in PBS/T. For detection, membranes were incubated in chemiluminescent
HRP substrates (Millipore, Merck, Darmstadt, Germany). Primary antibodies were
directed against MDM2 (4B2, a generous gift from Dr. Jean-Christophe Marine), p53
(OP29; Calbiochem), P(Tyr1022/Tyr1023) JAK1 (sc-16773-R, Santa Cruz Biotech-
nology), JAK1 (J24320, Transduction Laboratories, San Jose, CA, USA), P(Tyr1007/
Tyr1008) JAK2 (sc-16566-R; Santa Cruz Biotechnology), JAK2 (06-255; Upstate,
Merck), P(Tyr1054/Tyr1055) TYK2 (9321; Cell Signaling, Danvers, MA, USA), TYK2
(sc-169; Santa Cruz Biotechnology), P(Tyr705) STAT3 (sc-8059, Santa Cruz
Biotechnology), STAT3 (sc-8019, Santa Cruz Biotechnology), P(Tyr694) STAT5
(4322; Cell Signaling), STAT5 (sc-835; Santa Cruz Biotechnology), CRTC2 (custom-
made; Enogene, Nanjing, China), CRTC3 (A302-703; Bethyl Laboratories,
Montgomery, TX, USA), P(Ser133) CREB (9198; Cell Signaling), CREB (48H2;
Cell Signaling), Histone H3 (9715; Cell Signaling), MYC (sc-40; Santa Cruz
Biotechnology), FLAG (F1804; Sigma-Aldrich), α-tubulin (T6199; Sigma-Aldrich),
β-Actin (sc-47778; Santa Cruz Biotechnology).
Where needed, membranes were stripped in 2% SDS, 20 mM β-mercaptoethanol,
62.5 Tris-HCl, pH 6.7 for 30 min at 50 °C. Before incubation with antibodies,
membranes where blocked in 5% milk or 2% BSA in PBS/T.
Immunoprecipitation. Cells were rinsed once in ice-cold PBS before addition
of lysis buffer (50 mM HEPES, pH 8.0, 150 mM NaCl, 0.5% Triton-X 100, protease
inhibitors (Complete; Roche), 5 mM NaF, 5 mM β-glycerophosphate, 1 mM
Na3VO4). After 15 min incubation on ice, cells were scraped off and incubated
15 min on ice with a short vortex every 3–5 min. The lysate was spun down at
10 000 × g for 10 min and supernatant was precleared with protein A or G beads for
60 min. Precleared lysate was then incubated with anti-FLAG affinity gel (Sigma-
Aldrich), anti-MYC affinity matrix (Covance, BioLegend, San Diego, CA, USA) or
protein A beads (GE Healthcare) with nonspecific IgG or anti-STAT3 (sc-482; Santa
Cruz Biotechnology) for 6 h, and rinsed four times in lysis buffer before SDS-PAGE.
Fractionation. For separation of cells into cytoplasm and nuclei, cells were
rinsed once in ice-cold PBS and scraped off in PBS with 5 mM NaF, 5 mM
β-glycerophosphate, 1 mM Na3VO4. After centrifugation (5 min, 700 × g, 4 °C) cells
were washed once, spun down and resuspended in hypoton lysis buffer (20 mM
Tris-HCl, pH 7.5, 20 mM NaCl, 0.2 mM EDTA, protease inhibitors (Complete;
Roche), 5 mM NaF, 5 mM β-glycerophosphate, 1 mM Na3VO4). After incubation
10 min on ice, NP-40 was added to a final concentration of 0.02% followed by 10
strokes with a tight piston in a Dounce homogenizer. Nuclei were spun down at
1200 × g for 7 min at 4 °C and rinsed twice in hypoton lysis buffer.
For the more stringent fractionation, cells were rinsed once in ice-cold PBS before
addition of modified RIP (mRIPA) lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl,
1% NP-40, 1 mM EDTA, 0.25 deoxycholate, protease inhibitors (Complete; Roche),
5 mM NaF, 5 mM β-glycerophosphate, 1 mM Na3VO4). After 15 min incubation on
ice, cells were scraped off and incubated 15 min on ice with a short vortex every
3–5 min. The lysate was spun down at 10 000 × g for 10 min and pellet was rinsed
twice in mRIPA.
Sample preparation and MS analysis. For quantitative comparison of the
p53−/− and p53−/−;mdm2−/− MEFs proteomes, we applied stable isotope by amino
acids in cell culture (SILAC)-based GeLCMS approach essentially as described.51
SILAC-labeled lysates from p53−/− and p53−/−;mdm2−/− MEFs were mixed 1 : 1,
separated on a NuPAGE gel (Invitrogen) and stained with Novex Colloidal Blue
(Invitrogen, Thermo Fisher Scientific). After rinsing of the gel, protein bands were
excised from the gel, rinsed twice in 50 : 50 EtOH/50 mM ammonium bicarbonate
Figure 8 Regulation of STAT–CRTC interplay by MDM2. See text for details
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(ABC), dehydrated with acetonitrile (ACN), reduced with 10 mM DTT in 50 mM
ABC, dehydrated with ACN, alkylated with 55 mM chloroacetamide, dehydrated with
ACN before rehydration in 12.5 ng/ml trypsin in 50 mM ABC and incubated
overnight at 37 °C. The following day peptides were extracted by two rounds of 1%
trifluoroacetic acid in 30% ACN incubation followed by three rounds of ACN
incubation. Acetonitrile was evaporated before desalting peptides on stage tips.
The LC setup was essentially the same as described previously.52 The peptide
mixtures were analyzed using an Agilent 1100 nanoflow system (Agilent
Technologies, Santa Clara, CA, USA) connected online to an LTQ-Orbitrap Velos
mass spectrometer (Thermo Fisher Scientific) equipped with a nanoelectrospray ion
source (Proxeon Biosystems, Thermo Fisher Scientific). For chromatographic
separation, peptides were injected into a fused silica column packed in-house with
3 μmC18 beads (Reprosil) (Dr. Maisch, Ammerbuch-Entringen, Germany), applying a
120- min gradient from 8 to 64% acetonitrile in 0.5% acetic acid at a flow rate of
250 nl/min. We set up the instrument methods for the LTQ-Orbitrap Velos in the data-
dependent mode and the 10 most intense peaks were chosen for MS/MS
fragmentation with CID activation, FTMS resolution was 60 000, normalized collision
energy of 35%, activation q= 0.25 and activation time of 20 ms. Ions selected
for fragmentation were dynamically excluded for 45 s, and lock mass ions m/z
391.284266, 429.0887724, 445.120024, 503.107515 and 519.138815 were used for
internal mass calibration.53
Processing of the raw files was done with MaxQuant software (version 1.0.13.13)
essentially as described.54 In brief, peak lists were generated by the Quant console of
MaxQuant program with the following parameters used for searching: double SILAC
with labels Arg6/Lys4; maximum two missed trypsin cleavages; six most intense
peaks per 100 Da interval used for MS/MS peak lists; mass tolerance was 7 ppm on
precursors and 0.5 Da (CID) for fragment ions. A fixed modification was
carbamidomethyl (C), and variable modifications were oxidation (M) and N-term
protein acetylation.
The MaxQuant-generated peak lists were searched by Mascot v.2.3 (http://www.
matrixscience.com) against the mouse International Protein Index database v.3.61.
The acquired Mascot DAT files together with the raw files were processed and
quantified by the Identify console of MaxQuant with the following parameters: peptide,
protein and site of modifications false discovery rate was below 1%, as assessed by
the number of hits in the reverse database; minimum peptides length was six; and a
minimum of one unique peptide for protein identification was required. All unmodified
and modified peptides were used for protein quantification based on both razor and
unique peptides requiring a minimum ratio count of two. Only the proteins identified by
at least two peptides were accepted.
Bioinformatics. The list of proteins considered to be differing significantly
between the two MEF genotypes coming from the SILAC experiment was imported
into the MetaCore software (Thomson Reuters, New York, NY, USA). To check how
many of them were regulated at transcriptional level by STATs, we used the 'Expand
by one interaction' algorithm, centering it in STATs genes and filtering
for 'downstream' for direction of the interaction and 'Transcription regulation' for
mechanism. From the resulting set, we retrieved the proteins originating from our
experiment and used GProX55 and Cytoscape56 for visualization of results.
Chromatin immunoprecipitation. Cells were crosslinked in PBS contain-
ing 2 mM disuccinimidyl glutarate (ProteoChem, Loves Park, IL, USA) for 30 min,
followed by 10 min crosslinking in PBS containing 1% formaldehyde and finally
quenched with 0.125 M glycine (all at room temperature). Crosslinked cells were
washed repeatedly in PBS, resuspended in lysis buffer (0.1% SDS, 1% Triton-X
100, 150 mM NaCl and 20 mM HEPES pH 7.6) and sonicated using a Bioruptor
(Diagenode, Seraing, Belgium). Chromatin was immunoprecipitated using antibody
against CRTC2 (A300-637A; Bethyl Laboratories) and Protein A/G agarose beads
(Santa Cruz; sc-2003) overnight at 4 °C. IPs were performed in 1 ml aliquots using
3 μg of antibody. Immunocomplexes were washed extensively and chromatin was
eluted and decrosslinked overnight at 65 °C. DNA was subsequently phenol/
chloroform purified and ethanol precipitated.
Next generation sequencing. For mRNA-seq 1 μg total RNA was
incubated with poly-dT beads to isolate polyadenylated RNA, subjected to
fragmentation and cDNA synthesis followed by library preparation (TruSeq RNA
Sample Prep kit v2) performed according to the manufacturer’s (Illumina, San
Diego, CA, USA) instructions. ChIP-seq libraries were constructed according to the
manufacturer's instructions (Illumina) as described previously.57 Sequencing was
carried out on a HiSeq1500 platform (Illumina).
RNA-seq and ChIP-seq data analysis. Sequencing reads were mapped
to the mm9 genome with STAR58 and further analyzed using HOMER.59 Differential
gene expression was determined using DESeq,60 based on two independent
biological replicates. CTRC2 peaks were identified using HOMER59 based on two
biological independent CRTC2 ChIP-seq experiments. Replicate concordant CRTC2
peaks identified in forskolin and forskolin+P6-treated cells were used for further
analysis. Differential CRTC2 binding was evaluated using EdgeR,61 based on two
independent biological experiments. The UCSC Genome Browser62 was used for
data visualization. De novo motif analysis was performed using HOMER.59
Sequencing data are available from the Gene Expression Omnibus (GEO) under
accession number GSE 82282.
Chromosome conformation capture (3C). 3C was carried out
essentially as described elsewhere.63,64 Cells were fixed in 2% formaldehyde for
10 min at RT, quenched with 0.125 M glycine for 5 min at RT followed by 15 min on
ice and washed twice with phosphate-buffered saline (PBS). Cells where spun down
at 1200 × g for 5 min at 4 °C. Approximately 6 × 106 cells were aliquoted and lysed
in 10 ml lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 0.2% Igepal CA-420, Complete
EDTA-free protease inhibitor cocktail (Roche)), incubated for 30 min rotating in cold
room and nuclei was spun down at 1200 × g for 5 min at 4 °C. Nuclei was washed
once in 1 ml 1.25 × NEBuffer2 (NEB) and resuspended with 1.25 × NEBuffer2 to a
total volume of 358 μl. Then 11 μl of 10% SDS was added followed by incubation at
37 °C for 1 h with gently agitation (10–20 r.p.m.). The SDS was quenched by adding
75 μl 10% Triton-X 100 and incubated at 37 °C for 1 h with gentle agitation. Forty
microliters were taken out from every aliquot and used as undigested control.
To digest chromatin, 1500U of HindIII (New England Biolabs, Ipswich, MA, USA)
was added to each aliquot and incubated at 37 °C overnight with gentle agitation.
Forty microliters were taken out from every aliquot and used as digested control. After
digestion, ligation was performed by adding ligation-mixture (1 × ligation buffer (NEB
B0202S), 1 mg/ml BSA, 400U T4 DNA ligase (NEB M0202S)) to digested chromatin
mixture in a total volume of 1 ml. Ligation was done at 16 °C 4 h-ON followed by
30 min incubation at RT. Reversal of crosslinking and degradation of proteins was
done by adding 60 μl 10 mg/ml of proteinase K (03115879001; Roche) to ligated
sample and 2,5 μl Proteinase K to digested and undigested controls followed by
incubation at 65 °C and shaking at 800 r.p.m. ON. Additional Proteinase K was added
(60 μl 10 mg/ml) and incubation at 65 °C was continued for 2 h. Samples were cooled
to room temperature and treated with 10 μl (ligated sample) or 0.5 μl (digested and
undigested controls) 10 mg/ml RNase A and incubated at 37 °C for 1 h.
DNA was purified by thorough mixing with 1 : 1 phenol pH 8.0 (Sigma P4557) and
then spun down at 3500 r.p.m. for 10 min at RT. The aqueous phase was carefully
transferred to a new tube. Extraction was repeated using 1 : 1 of phenol pH
8.0/chloroform (Sigma-Adrich). DNA was precipitated by adding 2.5 × volume of ice
cold 100% EtOH and 0.1 × volume of 3 M sodium acetate pH 4.5 followed by
overnight incubation at − 20 °C or at − 80 °C for 1 h. Samples were spun down 4 °C
for 3 min and washed 3 × in freshly made 70% EtOH. Pellet was resuspended in
25 μl 1 × TE at 37 °C for ~ 30 min and DNA concentration was determined.
A control library was prepared by digesting and randomly ligating non-crosslinked
purified DNA from bacterial artificial chromosome (BAC) (RP23-77N6, 236 kb)
(BACPAC Resources, Oakland, CA, USA) that span the genomic region investigated
by 3C. BAC RP23-77N6 was digested and ligated essentially as described in
Naumova et al.65 with minor modifications. In short, BAC RP23-77N6 was grown on
LB plates containing chloramphenicol and DNA purified using miniprep (Sigma-
Adrich) lysis solution followed by addition of 0.7 × isopropanol for precipitation. BAC
was digested in a total volume of 420 μl by using 30 μg BAC DNA, 1 × NEBuffer2,
1500 U HindIII and 1 mg/ml BSA. DNA was purified by very gentle addition of phenol
pH 8.0/chloroform followed by very gentle mixing and then spun down at 18 000 × g
at RT for 5 min. The aqueous phase was transferred to a new tube and precipitated
using 0.1 × volume 3 M sodium acetate pH 4.5, 2.5 × volume 100% EtOH and 20 μg
glycogen. Digested BAC was ligated in a total volume of 1 ml as described above for
3C sample and purified by adding 1 : 1 volume of phenol pH 8.0/chloroform and
precipitated as described above. Pellet was resuspended in 50 μl TE buffer at 37 °C
for ~ 30 min. 3C control library quality was checked by running DNA on 0.8%
agarose gel.
Primers (Pentabase) was designed using http://www.pristionchus.org/3CPrimer-
Design/ and following the guidelines described in Frohler and Dieterich.66 3C primers
are listed in Supplementary Table S2.
Efficacy of primers was tested using twofold dilution series to make sure detection
of product was performed within the linear range and test of digest efficiency for all
investigated sites (CEBPδ TSS, Control and Enhancer) was performed using
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digested and undigested controls (Supplementary Figure S5C). Finally, detection of
interaction was done by real-time qPCR using combination of unidirectional primers
(Fw2–Fw4 and Fw2–Fw6 for detection of interaction between Cebpd TSS and control
sites or enhancer, respectively) and normalized to BAC control library. Standard
deviation was taken from two biological replicates and four technical replicates of the
3C protocol in each treatment.
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